scholarly journals RETROSPECTIVE REAL-WORLD OUTCOMES FOR ALK-REARRANGED LUNG CANCER PATIENTS RECEIVING ALK-RECEPTOR TYROSINE KINASE INHIBITORS

2021 ◽  
pp. 100157
Author(s):  
Amanda J.W. Gibson ◽  
Adrian Box ◽  
Michelle L. Dean ◽  
Anifat A. Elegbede ◽  
Desiree Hao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Cancer Patients ◽  
Tyrosine Kinase Inhibitors ◽  
Receptor Tyrosine Kinase ◽  
Real World ◽  
Kinase Inhibitors ◽  
Lung Cancer Patients ◽  
Receptor Tyrosine Kinase Inhibitors

scholarly journals Elucidating the mechanisms of resistance to tyrosine kinase inhibitors in lung cancer patients

2017 ◽  
Vol 1 (Special Issue) ◽  
pp. 76-76
Author(s):  
Asim Joshi ◽  
Anuradha Chougule ◽  
Pratik Chandrani ◽  
Vaishakhi Trivedi ◽  
Prajish Iyer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Cancer Patients ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Mechanisms Of Resistance ◽  
Lung Cancer Patients

scholarly journals Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

2013 ◽  
Vol 15 (4) ◽  
pp. 415-453 ◽  
Author(s):  
Neal I. Lindeman ◽  
Philip T. Cagle ◽  
Mary Beth Beasley ◽  
Dhananjay Arun Chitale ◽  
Sanja Dacic ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Cancer Patients ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Molecular Testing ◽  
Lung Cancer Patients ◽  
Selection Of
Sign in / Sign up

Export Citation Format

Share Document